Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFLAZACORT vs DEGARELIX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFLAZACORT vs DEGARELIX: Safety Overview

Metric DEFLAZACORT DEGARELIX
Total FAERS Reports 3,831 3,779
Deaths Reported 149 484
Death Rate 3.9% 12.8%
Hospitalizations 592 1,333
Average Patient Age 25.7 yrs 74.0 yrs
% Female Patients 15.1% 0.7%
FDA Approval Date Apr 25, 2024 Dec 24, 2008
Manufacturer Cranbury Pharmaceuticals, LLC Ferring Pharmaceuticals Inc.
Route ORAL N/A
Marketing Status Prescription Prescription